menu search

Turnstone biologics presents preclinical data highlighting potential for selected tumor-infiltrating lymphocyte (til) therapy in solid tumors at the 2023 society for immunotherapy of cancer (sitc) ann

Presentations showcase Turnstone’s novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for t...

November 3, 2023, 10:00 am

Ozempic just shrugged off a challenge from viatris. what does this mean for investors?

Viatris tried to invalidate three of the patents covering Novo Nordisk's Ozempic. The courts rebuffed two of those attempts, but the third will be ...

October 31, 2023, 5:05 am

Atossa therapeutics' (z)-endoxifen being evaluated as alternative treatment for ductal carcinoma in situ

Atossa Therapeutics Inc (NASDAQ:ATOS)'s selective estrogen receptor modulator (Z)-endoxifen is being evaluated...

October 30, 2023, 3:11 pm

Syndax: biotech to watch with regulatory filings before end of 2023

Syndax Pharmaceuticals, Inc. reported positive results from its phase 1/2 trial using revumenib to treat relapsed/refractory leukemia patients. The tr...

October 13, 2023, 2:52 pm

Harmony biosciences stock drops on disappointing study results

Harmony Biosciences Holdings Inc shares sank 38% to $18.66 in late-morning trading on Friday after the pharmaceutical company reported topline results...

October 13, 2023, 11:29 am

Onln: a year later, outlook still very mixed

The ProShares Online Retail ETF is being evaluated as an investment at the current market price. Rising...

October 10, 2023, 10:48 am

Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023

SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immun...

October 9, 2023, 12:10 pm

Alx oncology stock doubles on early data from phase ii cancer trial

ALX Oncology Holdings Inc saw its stock value double in pre-market trading on the heels of promising interim data from a phase II study assessing th...

October 3, 2023, 8:47 am

Aviv clinics highlights case report showing hyperbaric oxygen therapy improves post-stroke rehabilitation, specifically hand motor recovery

The case report evaluated the patient’s hand motor function and functional MRI after HBOT, and analys...

October 2, 2023, 5:04 pm

Mara vs. riot: which bitcoin mining stock is better?

In this piece, I evaluated two bitcoin mining stocks, Marathon Digital Holdings (NASDAQ:MARA) and Riot ...

September 29, 2023, 11:44 pm

Pml: the macro-environment keeps pressuring this option

PIMCO Municipal Income Fund II is evaluated as an investment option at its current market price. The fu...

September 20, 2023, 1:06 pm

Amsg named orangeslices’ 2024 elev8 govcon honoree

WASHINGTON, Sept. 15, 2023 (GLOBE NEWSWIRE) — AMSG has just been recognized as being among OrangeSlices’ 2024 Elev8 GovCon honorees. We are honore...

September 15, 2023, 1:05 pm

Nektar (nktr) up on positive new data from eczema study

Nektar (NKTR) gains on positive new data for its pipeline candidate, rezpegaldesleukin, evaluated from ...

September 14, 2023, 9:01 am

Kiora pharmaceuticals to present topline results from the abacus study at american academy ophthalmology (aao); phase 1b study evaluating kio-301 in retinitis pigmentosa

Encinitas, California--(Newsfile Corp. - September 14, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced that r...

September 14, 2023, 7:01 am

Why major us banks are dialing back chances of a recession

Few words carry as much weight in the volatile world of finance as "recession." When the economy falters, businesses suffer, jobs are lost, and financ...

September 11, 2023, 2:48 pm

H&r block recognized as a 2023 fortune best workplace in financial services & insurance

Great Place to Work and Fortune evaluated comprehensive feedback from associates on their workplace exp...

September 8, 2023, 7:36 pm

Biocardia announces interim efficacy results in phase iii pivotal cardiamp cell therapy heart failure trial

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the...

September 5, 2023, 11:15 am

Major changes in credit score calculations unveiled

The world of credit scores is changing dramatically as substantial modifications in credit score formulas are revealed. These changes will have an imp...

August 31, 2023, 2:32 pm

Merck and eisai cull late-stage study for head and neck cancer therapy

Merck & Co Inc (NYSE:MRK) and research partner Eisai said they are halting a late-stage trial that used a combination of drugs to treat a type of head...

August 25, 2023, 7:58 am

Travere therapeutics to present abstracts at the society for the study of inborn errors of metabolism annual symposium 2023

SAN DIEGO, Aug. 24, 2023 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present clinical data fr...

August 24, 2023, 8:30 pm


Search within

Pages Search Results: